China Medical University Hospital, Taichung
VEGF gene BstUI polymorphism is a genetic marker for oral cancer
Published in Physician Law Weekly, August 3rd, 2005
According to recent research from Taiwan, "oral cancer is one of the most common malignant diseases in Taiwan. The incidence of male oral cancer is 9.01 times than that of female."
"The formation or progression of oral cancer may be associated with a polymorphism of the vascular endothelial growth factor (VEGF) gene. The most frequently seen polymorphism is BstUI (C to T) located at the -460th nucleotide upstream of the VEGF gene. We investigated whether this polymorphism could be a genetic marker of oral cancer," said K.T. Ku and colleagues, China Medical University...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2005-08-03)
More Articles from Physician Law Weekly
- BlueCross BlueShield of Tennessee
Health insurance provider announces partnership to utilize technology - Cordis Corp.
Company to ask judge to overturn Cypher patent verdict - Defibtech
New Jersey orders automated external defibrillators for police cars - Emisphere Technologies, Inc.
Company announces sale of Connecticut facility - Ethics
Experts discuss use of human stem cells in ape and monkey brains - Health Promotion
Breastfeeding protection initiative aims to raise awareness of rights - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
